Novel Immunotherapy Developed by City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients
Natural killer (NK) cells engineered with chimeric antigen receptor (CAR) cells to better fight COVID-19 LOS ANGELES–(BUSINESS WIRE)–City of Hope researchers have engineered an immunotherapy using natural killer cells with a specific molecule that can target the SARS-CoV-2 virus’ spike protein, providing a novel therapeutic pathway for the treatment of COVID-19 and other infections that … [Read more…]